{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T19:45:28Z","timestamp":1765568728180,"version":"3.48.0"},"reference-count":0,"publisher":"Clinical Care Targeted Communications Group, LLC","issue":"Spec. No. 15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.37765\/ajmc.2025.89854","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T19:16:53Z","timestamp":1765567013000},"page":"SP1084","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 Receptor Agonists: Trend, Necessity, or Blessing?"],"prefix":"10.37765","volume":"31","member":"24492","published-online":{"date-parts":[[2025,12,8]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T19:16:53Z","timestamp":1765567013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/glp-1-receptor-agonists-trend-necessity-or-blessing-"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":0,"journal-issue":{"issue":"Spec. No. 15","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2025.89854","relation":{},"ISSN":["1088-0224","1936-2692"],"issn-type":[{"value":"1088-0224","type":"print"},{"value":"1936-2692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}